Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
https://www.alvarezandmarsal.com/insights/is-omicron-our-way-out
In Part II of our podcast, the discussion continues and dives into the impact of COVID-19 on patient volume, specifically as it relates to...
Managing your workforce is continuously evolving and can be enhanced by technology that can improve efficiency and decrease costs. In the latest episode of...
A&M Healthcare Industry Group Managing Director, Michael Niarchos, moderates a conversation on the emerging trends in the Pharmacy and PBM ecosystem. Joined by Ryan...
